C-Peptide Response and HLA Genotypes in Subjects With Recent-Onset Type 1 Diabetes After Immunotherapy With DiaPep277: An Exploratory Study

OBJECTIVE: To investigate whether lower risk HLA class II genotypes would influence the efficacy of DiaPep277 therapy in protecting β-cell function evaluated by C-peptide secretion in recent-onset type 1 diabetic subjects. RESEARCH DESIGN AND METHODS: Data were collected from type 1 diabetic subject...

Descripción completa

Detalles Bibliográficos
Autores principales: Buzzetti, Raffaella, Cernea, Simona, Petrone, Antonio, Capizzi, Marco, Spoletini, Marialuisa, Zampetti, Simona, Guglielmi, Chiara, Venditti, Chiara, Pozzilli, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2011
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3198071/
https://www.ncbi.nlm.nih.gov/pubmed/21896927
http://dx.doi.org/10.2337/db10-0560

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3198071/
https://www.ncbi.nlm.nih.gov/pubmed/21896927
http://dx.doi.org/10.2337/db10-0560

Ejemplares similares